We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
-$248M
(-17%)
Cap. Flow
-$400M
Cap. Flow
% of AUM
-32.99%
Top 10 Holdings %
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$16.2M |
| 2 |
Adaptive Biotechnologies
ADPT
|
+$15.8M |
| 3 |
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
|
+$12.7M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$11.9M |
| 5 |
Simulations Plus
SLP
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agios Pharmaceuticals
AGIO
|
+$16M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$12.2M |
| 3 |
BHP
BHP
|
+$10.7M |
| 4 |
Allogene Therapeutics
ALLO
|
+$8.56M |
| 5 |
Willis Towers Watson
WTW
|
+$6.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.03% |
| 2 | Technology | 7.51% |
| 3 | Consumer Discretionary | 5.23% |
| 4 | Financials | 5.2% |
| 5 | Industrials | 4.75% |
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q3 2020 Portfolio in Review
As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.
- Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
- Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
- Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
- Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
- Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
- Maven Securities opened 297 new positions and closed 223 in Q3 2020.
- Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.
Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.